Effects of intensive glucose lowering in treatment of type 2 diabetes mellitus on cardiovascular outcomes: A meta-analysis of data from 58,160 patients in 13 randomized controlled trials

International Journal of Cardiology

Volumn 218, Issue , 2016, Pages 50-58

  Fang, Hong Juan ^a   Zhou, Yu Hao ^b   Tian, Yong Ji ^a   Du, Han Yang ^a   Sun, Yan Xia ^c   Zhong, Li Yong ^a  

^a CAPITAL MEDICAL UNIVERSITY   (China)

^b SHANGHAI SEVENTH PEOPLE S HOSPITAL   (China)

^c CAPITAL MEDICAL UNIVERSITY   (China)

Author keywords

Cardiovascular; Intensive glucose lowering; Meta analysis; Type 2 diabetes mellitus

Indexed keywords

ANTIDIABETIC AGENT; GLIPIZIDE; INSULIN; METFORMIN; PIOGLITAZONE; ROSIGLITAZONE; SITAGLIPTIN; SULFONYLUREA; GLUCOSE BLOOD LEVEL;

ARTICLE; CEREBROVASCULAR ACCIDENT; CONGESTIVE HEART FAILURE; HEART DEATH; HEART INFARCTION; HUMAN; META ANALYSIS; MORTALITY; NON INSULIN DEPENDENT DIABETES MELLITUS; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); RISK BENEFIT ANALYSIS; RISK FACTOR; RISK REDUCTION; SYSTEMATIC REVIEW; BLOOD; CARDIOVASCULAR DISEASES; DIABETES MELLITUS, TYPE 2; DRUG EFFECTS; GLUCOSE BLOOD LEVEL; METABOLISM; PROCEDURES; TREATMENT OUTCOME;

BLOOD GLUCOSE; CARDIOVASCULAR DISEASES; DIABETES MELLITUS, TYPE 2; HUMANS; HYPOGLYCEMIC AGENTS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; TREATMENT OUTCOME;

EID: 84969930811     PISSN: 01675273     EISSN: 18741754     Source Type: Journal    
DOI: 10.1016/j.ijcard.2016.04.163     Document Type: Article

References (35)

1. D.C. Goff Jr., H.C. Gerstein, and H.N. Ginsberg Prevention of cardiovascular disease in persons with type 2 diabetes mellitus: current knowledge and rationale for the action to control cardiovascular risk in diabetes (ACCORD) trial Am. J. Cardiol. 99 2007 4i 20i
2. UK Prospective Diabetes Study (UKPDS) Group Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33) Lancet 352 1998 837 853
3. The Diabetes Control and Complications Trial Research Group The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus N. Engl. J. Med. 329 1993 977 986
4. S.E. Moss, R. Klein, B.E. Klein, and S.M. Meuer The association of glycemia and causespecific mortality in a diabetic population Arch. Intern. Med. 154 1994 2473 2479
5. E. Selvin, S. Marinopoulos, and G. Berkenblit Meta-analysis: glycosylated hemoglobin and cardiovascular disease in diabetes mellitus Ann. Intern. Med. 141 2004 421 431
6. H.C. Gerstein, J. Pogue, and J.F. Mann The relationship between dysglycaemia and cardiovascular and renal risk in diabetic and non-diabetic participants in the HOPE study: a prospective epidemiological analysis Diabetologia 48 2005 1749 1755
7. I.M. Stratton, A.I. Adler, and H.A. Neil Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study BMJ 321 2000 405 412
8. The Action to Control Cardiovascular Risk in Diabetes Study Group Effects of intensive glucose lowering in type 2 diabetes N. Engl. J. Med. 358 2008 2545 2559
9. P. Gæde, H. Lund-Andersen, and H.-H. Parving Effect of a multifactorial intervention on mortality in type 2 diabetes N. Engl. J. Med. 358 2008 580 591
10. C.Y. Zhang, A.J. Sun, and S.N. Zhang Effects of intensive glucose control on incidence of cardiovascular events in patients with type 2 diabetes: a meta-analysis Ann. Med. 42 2010 305 315
11. S.J. Griffin, K. Borch-Johnsen, and M.J. Davies Eff ect of early intensive multifactorial therapy on 5-year cardiovascular outcomes in individuals with type 2 diabetes detected by screening (ADDITION-Europe): a cluster-randomised trial Lancet 378 2011 156 167
12. The ADVANCE Collaborative Group Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes. N. Engl. J. Med 358 2008 2560 2572
13. A. Araki, S. Iimuro, and T. Sakurai Long-term multiple risk factor interventions in Japanese elderly diabetic patients: the Japanese elderly diabetes intervention trial - study design, baseline characteristics and effects of intervention Geriatr. Gerontol. Int. 12 Suppl. 1 2012 7 17
14. K. Malmberg, L. Ryden, and H. Wedel Intense metabolic control by means of insulin in patients with diabetes mellitus and acute myocardial infarction (DIGAMI 2): effects on mortality and morbidity Eur. Heart J. 26 7 2005 650 661
15. J.B. Green, M.A. Bethel, and P.W. Armstrong Effect of sitagliptin on cardiovascular outcomes in type 2 diabetes N. Engl. J. Med. 373 2015 232 242
16. J.A. Dormandy, B. Charbonnel, and D.J.A. Eckland Secondary prevention of macrovascular events in patients with type 2 diabetes in the PROactive study (PROspective pioglitAzone clinical trial in macrovascular events): a randomised controlled trial Lancet 366 2005 1279 1289
17. P.D. Home, S.J. Pocock, and H. Beck-Nielsen Rosiglitazone evaluated for cardiovascular outcomes - an interim analysis N. Engl. J. Med. 357 2007 28 38
18. Prepared for the University Group Diabetes Program Effects of hypoglycemic agents on vascular complications in patients with adult-onset diabetes VII. Mortality and selected nonfatal events with insulin treatment JAMA 240 1978 37 42
19. UK Prospective Diabetes Study (UKPDS) Group Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34) Lancet 352 1998 854 865
20. C. Abraira, J. Colwell, and F. Nuttall Cardiovascular events and correlates in the veterans affairs diabetes feasibility trial veterans affairs cooperative study on glycemic control and complications in type II diabetes Arch. Intern. Med. 157 1997 181 188
21. W. Duckworth, C. Abraira, and T. Moritz Glucose control and vascular complications in veterans with type 2 diabetes N. Engl. J. Med. 360 2009 129 139
22. D. Moher, A. Liberati, and J. Tetzlaff Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement PLoS Med. 6 2009 e1000097
23. J. Higgins, and D.G. Altman Assessing risk of bias in included studies J. Higgins, S. Green, Cochrane Handbook for Systematic Reviews of Interventions 5.0.1 2008 Cochrane Collaboration Oxford, England (chap 8)
24. R. DerSimonian, and N. Laird Meta-analysis in clinical trials Control. Clin. Trials 7 1986 177 188
25. A.E. Ades, G. Lu, and J.P. Higgins The interpretation of random-effects metaanalysis in decision models Med. Decis. Making 25 2005 646 654
26. J.P. Higgins, S.G. Thompson, J.J. Deeks, and D.G. Altman Measuring inconsistency in meta-analyses BMJ 327 2003 557
27. J.J. Deeks, J. Higgins, and D.G. Altman Analysing data and undertaking meta-analyses Cochrane Handbook for Systematic Reviews of Interventions: Cochrane Book Series 243-296 2008
28. S.G. Thompson, and J.P. Higgins How should meta-regression analyses be undertaken and interpreted? Stat. Med. 21 11 2002 1559 1573
29. D.G. Altman, and J.M. Bland Interaction revisited: the difference between two estimates BMJ. 326 2003 219
30. X.H. Li, F.F. Yu, and Y.H. Zhou Association between alcohol consumption and the risk of incident type 2 diabetes: a systematic review and dose-response meta-analysis Am. J. Clin. Nutr. 103 3 2016 818 829
31. A. Tobias Assessing the influence of a single study in meta-analysis Stata Tech. Bull. 47 1999 15 17
32. M. Egger, G. Davey Smith, and M. Schneider Bias in meta-analysis detected by a simple, graphical test BMJ 315 1997 629 634
33. C.B. Begg, and M. Mazumdar Operating characteristics of a rank correlation test for publication bias Biometrics 50 1994 1088 1101
34. B. Hemmingsen, S.S. Lund, and C. Gluud Targeting intensive glycaemic control versus targeting conventional glycaemic control for type 2 diabetes mellitus Cochrane Database Syst. Rev. 11 2013 CD008143
35. C. Zhang, Y.-H. Zhou, and C.-L. Xu Efficacy of intensive control of glucose in stroke prevention: a meta-analysis of data from 59197 participants in 9 randomized controlled trials PLoS One 8 1 2013 e54465